Profil
Dustin S.
Sjuts is currently Chief Executive Officer & Director at Revelyx Bio, Inc. since 2026.
Formerly, Mr. Sjuts was President at Revance Therapeutics, Inc. from 2021 to 2024 and Business Unit Head-China at Galderma Holding SA from 2017 to 2018.
Education includes undergraduate studies at Illinois State University.
Postes actifs de Dustin Sjuts
| Sociétés | Poste | Début |
|---|
Anciens postes connus de Dustin Sjuts
| Sociétés | Poste | Fin |
|---|---|---|
| REVANCE THERAPEUTICS, INC. | President | 31/03/2024 |
Galderma Holding SA
Galderma Holding SA Pharmaceuticals: MajorHealth Technology Operates as a holding company whose subsidiaries manufactures and distributes dermatological & skin care products | Corporate Officer/Principal | 01/04/2018 |
Formation de Dustin Sjuts
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Revance Therapeutics, Inc.
Revance Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs for esthetics, skincare and therapeutics | Health Technology |
Illinois State University
Illinois State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Galderma Holding SA
Galderma Holding SA Pharmaceuticals: MajorHealth Technology Operates as a holding company whose subsidiaries manufactures and distributes dermatological & skin care products | Health Technology |
















